EPD Biotherapeutics

EPD Biotherapeutics

Developing innovative therapies with Engineered Protein Degraders.

Launch date
Employees
Market cap
-
Enterprise valuation
$15—22m (Dealroom.co estimates Jun 2022.)
Company register number 3108134482
Seoul South Korea (HQ)
Authorizing premium user...